The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations. 1984

M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill

Ro 03-8799, a lipophilic nitroimidazole with a basic side chain, has now been administered intravenously to 69 patients. The elimination half-life in plasma was 5.1 hr and the plasma concentration at 30 min was 14.8 micrograms/ml standardized to a dose of 1 g per square meter of surface area. Immediate symptoms of malaise, heat, sweating and disorientation limit the amount of the drug which may be given on any one occasion. However, a dose of 750 mg per square meter of surface area may be given combined with daily radiotherapy. Our data suggest that when given with a 20 fraction course of radiotherapy, sensitization of hypoxic cells may be achieved equal to a 10-fold increase in the dose of misonidazole above that presently permitted.

UI MeSH Term Description Entries
D008297 Male Males
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
January 1984, European journal of clinical pharmacology,
M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
May 1990, International journal of radiation oncology, biology, physics,
M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
September 1986, The British journal of radiology,
M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
May 1989, British journal of cancer,
M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
February 1986, The British journal of radiology,
M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
July 1986, International journal of radiation oncology, biology, physics,
M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
November 1988, International journal of radiation oncology, biology, physics,
M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
January 1991, Cancer chemotherapy and pharmacology,
M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
April 1989, International journal of radiation oncology, biology, physics,
M I Saunders, and P J Anderson, and M H Bennett, and S Dische, and A Minchinton, and M R Stratford, and M Tothill
July 1986, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!